Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Insider Selling: BridgeBio Pharma (NASDAQ:BBIO) CEO Sells $2,002,703.67 in Stock

Summary by themarketsdaily.com
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) CEO Neil Kumar sold 28,053 shares of the stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $71.39, for a total value of $2,002,703.67. Following the transaction, the chief executive officer owned 234,451 shares in the company, […]
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

1 Articles

themarketsdaily.comthemarketsdaily.com

Insider Selling: BridgeBio Pharma (NASDAQ:BBIO) CEO Sells $2,002,703.67 in Stock

BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) CEO Neil Kumar sold 28,053 shares of the stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $71.39, for a total value of $2,002,703.67. Following the transaction, the chief executive officer owned 234,451 shares in the company, […]

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

themarketsdaily.com broke the news in on Thursday, February 26, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Palo Alto icon

Palo Alto

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal